Research and analysis

RPC opinions 2015-17: Medicines and Healthcare products Regulatory Agency (DH)

Regulatory Policy Committee (RPC) opinions for Medicines and Healthcare products Regulatory Agency (MHRA) measures from the 2015-17 parliament

• From: Regulatory Policy Committee
• Published: 21 May 2018

Documents

DH MHRA Co-ordination of safety and risk materials for generic medicines

PDF, 191 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

DH MHRA E-correspondence via CESP

PDF, 177 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

DH MHRA Grouped Opinion (2017)

PDF, 189 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Published Regulatory Policy Committee (RPC) opinions for Medicines and Healthcare products Regulatory Agency measures from the 2015-17 parliament.

Published 21 May 2018